Stoop TF, Wu YHA, Oba A, Ali M, Feld IM, Al-Musawi MH, Jain A, Saiura A, Sauvanet A, Coppola A, Javed AA, Groot Koerkamp B, Miller BN, Hashimoto D, Caputo D, Kleive D, Sereni E, Kazemier G, Belfiori G, Ishida H, van Dam JL, Dembinski J, Akahoshi K, Roberts KJ, Tanaka K et al. (2025)
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study
Br J Cancer (in press)
DOI 10.1038/s41416-025-03025-1, PubMed 40328917

van Veldhuisen CL, Leseman CA, De Rijk FEM, Marques-Antunes J, Ausania F, Belyaev O, Berrevoet F, Boermeester MA, Boggi U, Bouwense SA, Bruno MJ, Busch OR, Conlon KC, Dokmak S, Falconi M, Ghorbani P, Gryspeerdt F, Haen R, Ibrahimli A, Izbicki JR, Krikke C, Kokkola A, Marique L, Mieog JSD, Nappo G et al. (2025)
Surgery for chronic pancreatitis across Europe (ESCOPA): prospective multicentre study
Br J Surg, 112 (4)
DOI 10.1093/bjs/znaf068, PubMed 40296656

Korenblik R, James S, Smits J, Díaz-Nieto R, Davis R, Chan BKY, Erdmann JI, Zijlstra IAJ, Arntz PJW, Kollmar O, Hoffmann MH, Vass DG, Lindsay R, Serenari M, Cappelli A, Gobardhan PD, Imani F, Suarez YF, Muños FG, Grünhagen DJ, Moelker A, Pieterman KJ, Kleeff J, Wohlgemuth WA, Herrero E et al. (2025)
Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trial
Lancet Reg Health Eur, 53, 101284
DOI 10.1016/j.lanepe.2025.101284, PubMed 40255933